Selected article for: "acute respiratory and lmwh molecular weight heparin"

Author: Qasim Agha, Osama; Berryman, Ryan
Title: Acute Splenic Artery Thrombosis and Infarction Associated with COVID-19 Disease
  • Cord-id: syusz85t
  • Document date: 2020_9_4
  • ID: syusz85t
    Snippet: Coronavirus 2019 disease (COVID-19) is a viral illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It emerged in Wuhan, China, in December 2019 and has caused a widespread global pandemic. The symptoms of COVID-19 can vary from mild upper respiratory symptoms to severe pneumonia with hypoxemic respiratory failure. Multiple studies and reports have reported a hypercoagulable state associated with this disease, and various recommendations have emerged to guide the use o
    Document: Coronavirus 2019 disease (COVID-19) is a viral illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It emerged in Wuhan, China, in December 2019 and has caused a widespread global pandemic. The symptoms of COVID-19 can vary from mild upper respiratory symptoms to severe pneumonia with hypoxemic respiratory failure. Multiple studies and reports have reported a hypercoagulable state associated with this disease, and various recommendations have emerged to guide the use of anticoagulants for prophylaxis. We are reporting a case of symptomatic acute splenic thrombosis causing splenic infarction in a patient suffering from a severe case of COVID-19 and despite the use of an intermediate dose of low-molecular-weight heparin (LMWH). The patient was treated with full-dose anticoagulation and was eventually discharged home on a direct oral anticoagulant.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and lmwh low molecular weight heparin: 1
    • abdominal pain and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low mortality: 1, 2
    • abnormal coagulation and lmwh low molecular weight heparin: 1, 2, 3
    • abnormal coagulation and low molecular weight: 1, 2, 3, 4, 5, 6, 7
    • abnormal coagulation and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • lmwh low molecular weight heparin and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh low molecular weight heparin and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh low molecular weight heparin and low mortality: 1, 2, 3, 4